The evidence base
Laser hair removal has been used clinically since the mid-1990s and is one of the most studied procedures in aesthetic dermatology. Multiple large peer-reviewed reviews document durable hair reduction with a low incidence of adverse events. The FDA cleared the first laser hair removal device in 1997 and has since cleared devices spanning every major wavelength and skin type.
What makes it safe
Three variables determine whether a treatment is safe:
- ·Device selection. Wavelength must match skin type. Alexandrite (755nm) for lighter skin. Nd:YAG (1064nm) for medium to dark skin.
- ·Operator training. Fluence, pulse width, and cooling need to be set by someone who understands the physics — not a template.
- ·Pre-screening. Medications, conditions, recent sun exposure, and skin changes are checked before every session, not just at intake.
Why safety varies so much across clinics
Real risks — and where they come from
Documented risks fall into three tiers:
- ·Common and temporary: redness, mild swelling around follicles, brief warmth. Resolves within hours to a day.
- ·Uncommon: temporary pigment change (hyperpigmentation or hypopigmentation), most often from sun exposure around treatment.
- ·Rare: blistering, scarring — nearly always tied to wrong device settings, wrong device for skin type, or treating over a recent sunburn.
Detailed breakdowns live in Common Side Effects and Risks and Contraindications.
What to look for in a program
- ·Multiple wavelengths available (at minimum Alexandrite and Nd:YAG).
- ·Skin typing done at consultation — not skipped.
- ·Trained clinicians, not template-driven technicians.
- ·Medical oversight from a licensed provider.
- ·Willingness to defer a session if your skin isn't ready that day.
The Stubble program is built around these standards. Schedule your enrollment consultation to see how they show up in practice.
Key takeaways
- · Laser hair removal has decades of clinical evidence and FDA clearance.
- · Safety depends on device selection, operator training, and pre-screening.
- · Serious complications almost always trace back to one of those three failures.
- · Medical-grade programs treat all six Fitzpatrick skin types safely.
- · Med-spas using a single generic device cannot safely treat every skin type.